Time‐Dependent Cardiovascular Treatment Benefit Model for Lipid‐Lowering Therapies
نویسندگان
چکیده
منابع مشابه
Estimating the incremental net health benefit of requirements for cardiovascular risk evaluation for diabetes therapies
PURPOSE To evaluate the advantages and disadvantages of pre-approval requirements for safety data to detect cardiovascular (CV) risk contained in the December 2008 U.S. Food and Drug Administration (FDA) guidance for developing type 2 diabetes drugs compared with the February 2008 FDA draft guidance from the perspective of diabetes population health. METHODS We applied the incremental net hea...
متن کاملNatural Therapies for Cardiovascular Diseases
The natural therapies are generally referred to as these complementary and alternative therapies that have specific biological activity to human, including aromatherapy, diet-based therapies, folk medicine, megavitamin therapy, neural therapy, phytotherapy, and herbal medicine. In recent years, the potential benefit of natural therapy in improving chronic diseases prognosis has drawn more and m...
متن کاملBenefit/risk of combination therapies.
It is now accepted that rheumatoid arthritis is not a benign disease, and has considerable morbidity and increased mortality rates. Monotherapy with disease modifying anti-rheumatic drugs (DMARDs) is often ineffective, and rarely leads to sustained clinical remission. Many clinical trials suggest the effectiveness of using combination therapies, and also the benefit of aggressive management ear...
متن کاملChallenges for treatment of cardiovascular diseases based on stem cells
Introduction: Cardiovascular diseases (CVD) are the primary cause of death worldwide, and the development of scar tissue in myocardium and also the irreversible destruction of cardiomyocytes are the main factors in their development. There are still limitations in medical treatment of CVD, despite the advances in the field of drug therapy and surgery for CVD. In recent years, research on stem c...
متن کاملStem cell therapies benefit Alport syndrome.
Patients with Alport syndrome progressively lose renal function as a result of defective type IV collagen in their glomerular basement membrane. In mice lacking the alpha3 chain of type IV collagen (Col4A3 knockout mice), a model for Alport syndrome, transplantation of wild-type bone marrow repairs the renal disease. It is unknown whether cell-based therapies that do not require transplantation...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of the American Heart Association
سال: 2020
ISSN: 2047-9980
DOI: 10.1161/jaha.120.016506